These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8820912)

  • 1. Effects of 19-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and lanosterol demethylase activity.
    Sonoda Y; Suzuki S; Udagawa K; Ota K; Tasaka R; Fukamachi Y; Sato Y
    Biol Pharm Bull; 1996 Jan; 19(1):57-61. PubMed ID: 8820912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.
    Trzaskos JM; Magolda RL; Favata MF; Fischer RT; Johnson PR; Chen HW; Ko SS; Leonard DA; Gaylor JL
    J Biol Chem; 1993 Oct; 268(30):22591-9. PubMed ID: 7693673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Obi N; Onoda M; Sakakibara Y; Sato Y
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2796-9. PubMed ID: 1464112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol.
    Leonard DA; Kotarski MA; Tessiatore JE; Favata MF; Trzaskos JM
    Arch Biochem Biophys; 1994 Apr; 310(1):152-7. PubMed ID: 8161198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ accumulation of 3 beta-hydroxylanost-8-en-32-aldehyde in hepatocyte cultures. A putative regulator of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity.
    Trzaskos JM; Favata MF; Fischer RT; Stam SH
    J Biol Chem; 1987 Sep; 262(25):12261-8. PubMed ID: 3624256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
    Iglesias J; Gibbons GF
    Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxolanosterol oximes: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Cusack KP; Leonard DA; Anderson JA
    J Lipid Res; 1994 Aug; 35(8):1333-44. PubMed ID: 7989858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells.
    Mayer RJ; Adams JL; Bossard MJ; Berkhout TA
    J Biol Chem; 1991 Oct; 266(30):20070-8. PubMed ID: 1657912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Leonard DA
    Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A relationship between the activities of hepatic lanosterol 14 alpha-demethylase and 3-hydroxy-3-methylglutaryl-CoA reductase.
    Marco de la Calle C; Hwang W; Pullinger CR; Gibbons GF
    Biochem J; 1988 Feb; 250(1):33-9. PubMed ID: 3355520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Anderson JA; Leonard DA; Cusack KP; Frye LL
    Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis by oxylanosterols.
    Panini SR; Sexton RC; Gupta AK; Parish EJ; Chitrakorn S; Rudney H
    J Lipid Res; 1986 Nov; 27(11):1190-204. PubMed ID: 3559385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity by ketoconazole. A role for cytochrome P-450 in the regulation of HMG-CoA reductase in rat intestinal epithelial cells.
    Gupta A; Sexton RC; Rudney H
    J Biol Chem; 1986 Jun; 261(18):8348-56. PubMed ID: 3722155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
    J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by azole antimycotics requires lanosterol demethylation, but not 24,25-epoxylanosterol formation.
    Favata MF; Trzaskos JM; Chen HW; Fischer RT; Greenberg RS
    J Biol Chem; 1987 Sep; 262(25):12254-60. PubMed ID: 3624255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hepatic lanosterol 14 alpha-demethylase gene expression by dietary cholesterol and cholesterol-lowering agents.
    Ness GC; Gertz KR; Holland RC
    Arch Biochem Biophys; 2001 Nov; 395(2):233-8. PubMed ID: 11697861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 24(S),25-oxidolanosterol.
    Panini SR; Delate TA; Sinensky M
    J Biol Chem; 1992 Jun; 267(18):12647-54. PubMed ID: 1618770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.
    Trzaskos JM; Ko SS; Magolda RL; Favata MF; Fischer RT; Stam SH; Johnson PR; Gaylor JL
    Biochemistry; 1995 Aug; 34(30):9670-6. PubMed ID: 7626636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.